Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample

被引:3
|
作者
Radestig, Maya Arvidsson [1 ,2 ]
Skoog, Ingmar [1 ,2 ,3 ]
Skillback, Tobias [1 ,2 ]
Zetterberg, Henrik [2 ,4 ,5 ,6 ,7 ]
Kern, Jurgen [1 ]
Zettergren, Anna [1 ,2 ]
Andreasson, Ulf [2 ,4 ]
Wetterberg, Hanna [1 ,2 ]
Kern, Silke [1 ,2 ,3 ]
Blennow, Kaj [2 ,4 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neuropsychiat,Epidemiol Unit, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Psychiat Cognit & Old Age Psychiat, Gothenburg, Sweden
[4] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden
[5] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England
[6] UK Dementia Res Inst UCL, London WC1N 3BG, England
[7] Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China
基金
欧盟地平线“2020”; 美国国家卫生研究院; 欧洲研究理事会;
关键词
Alzheimer's disease; Cerebrospinal fluid; CSF; biomarkers; Neurolfilament light; NfL; Neurogranin; ALZHEIMERS-DISEASE; NEUROFILAMENT LIGHT; TAU; NEUROGRANIN; DEMENTIA; PROTEIN; BRAIN; A-BETA(1-42); ASSOCIATION; MARKER;
D O I
10.1186/s13195-023-01193-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundNeurofilament light (NfL) and neurogranin (Ng) are promising candidate AD biomarkers, reflecting axonal and synaptic damage, respectively. Since there is a need to understand the synaptic and axonal damage in preclinical Alzheimer's disease (AD), we aimed to determine the cerebrospinal fluid (CSF) levels of NfL and Ng in cognitively unimpaired elderly from the Gothenburg H70 Birth Cohort Studies classified according to the amyloid/tau/neurodegeneration (A/T/N) system.MethodsThe sample consisted of 258 cognitively unimpaired older adults (age 70, 129 women and 129 men) from the Gothenburg Birth Cohort Studies. We compared CSF NfL and Ng concentrations in A/T/N groups using Student's T-test and ANCOVA.ResultsCSF NfL concentration was higher in the A-T-N+ group (p=0.001) and the A-T+N+ group (p=0.006) compared with A-T-N-. CSF Ng concentration was higher in the A-T-N+, A-T+N+, A+T-N+, and A+T+N+ groups (p<0.0001) compared with A-T-N-. We found no difference in NfL or Ng concentration in A+ compared with A- (disregarding T- and N- status), whereas those with N+ had higher concentrations of NfL and Ng compared with N- (p<0.0001) (disregarding A- and T- status).ConclusionsCSF NfL and Ng concentrations are increased in cognitively normal older adults with biomarker evidence of tau pathology and neurodegeneration.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration
    Hoglund, Kina
    Schussler, Nathalie
    Kvartsberg, Hlin
    Smailovic, Una
    Brinkmalm, Gunnar
    Liman, Victor
    Becker, Bruno
    Zetterberg, Henrik
    Cedazo-Minguez, Angel
    Janelidze, Shorena
    Lefevre, Isabel A.
    Eyquem, Stephanie
    Hansson, Oskar
    Blennow, Kaj
    NEUROBIOLOGY OF DISEASE, 2020, 134
  • [32] Age-related Changes in Biomarkers: Longitudinal Data From a Population-based Sample
    Glei, Dana A.
    Goldman, Noreen
    Lin, Yu-Hsuan
    Weinstein, Maxine
    RESEARCH ON AGING, 2011, 33 (03) : 312 - 326
  • [33] Protein Biomarkers in Parkinson's Disease: Focus on Cerebrospinal Fluid Markers and Synaptic Proteins
    Halbgebauer, Steffen
    Oeckl, Patrick
    Wirth, Katharina
    Steinacker, Petra
    Otto, Markus
    MOVEMENT DISORDERS, 2016, 31 (06) : 848 - 860
  • [34] Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction Are Altered in Parkinson's Disease and Related Disorders
    Nilsson, Johanna
    Constantinescu, Julius
    Nellgard, Bengt
    Jakobsson, Protik
    Brum, Wagner S.
    Gobom, Johan
    Forsgren, Lars
    Dalla, Keti
    Constantinescu, Radu
    Zetterberg, Henrik
    Hansson, Oskar
    Blennow, Kaj
    Backstrom, David
    Brinkmalm, Ann
    MOVEMENT DISORDERS, 2023, 38 (02) : 267 - 277
  • [35] Associations between cerebrospinal fluid synaptic protein biomarkers and cognitive function in bipolar disorder
    Knorr, Ulla
    Simonsen, Anja Hviid
    Nilsson, Johanna
    Brinkmalm, Ann
    Zetterberg, Henrik
    Blennow, Kaj
    Knudsen, Mark Bech
    Forman, Julie
    Miskowiak, Kamilla Woznica
    Hasselbalch, Steen Gregers
    Kessing, Lars Vedel
    BIPOLAR DISORDERS, 2024, 26 : 77 - 78
  • [36] Associations between cerebrospinal fluid synaptic protein biomarkers and cognitive function in bipolar disorder
    Knorr, Ulla
    Simonsen, Anja Hviid
    Nilsson, Johanna
    Brinkmalm, Ann
    Zetterberg, Henrik
    Blennow, Kaj
    Knudsen, Mark Bech
    Forman, Julie
    Miskowiak, Kamilla Woznica
    Hasselbalch, Steen Gregers
    Kessing, Lars Vedel
    JOURNAL OF PSYCHIATRIC RESEARCH, 2025, 184 : 288 - 296
  • [37] Association between Fine Particulate Matter Exposure and Cerebrospinal Fluid Biomarkers of Alzheimer ' s Disease among a Cognitively Healthy Population-Based Cohort
    Casey, Emma
    Li, Zhenjiang
    Liang, Donghai
    Ebelt, Stefanie
    Levey, Allan I.
    Lah, James J.
    Wingo, Thomas S.
    Huls, Anke
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2024, 132 (04)
  • [38] Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
    Irwin, David J.
    Trojanowski, John Q.
    Grossman, Murray
    FRONTIERS IN AGING NEUROSCIENCE, 2013, 5
  • [39] The prognostic value of cerebrospinal fluid axonal damage biomarkers in Multiple Sclerosis patients: a prospective study
    Virgilio, E.
    Vecchio, D.
    Crespi, I.
    Puricelli, C.
    Naldi, P.
    Cantello, R.
    Dianzani, U.
    Comi, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 208 - 208
  • [40] Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration
    Mattsson-Carlgren, Niklas
    Grinberg, Lea T.
    Boxer, Adam
    Ossenkoppele, Rik
    Jonsson, Magnus
    Seeley, William
    Ehrenberg, Alexander
    Spina, Salvatore
    Janelidze, Shorena
    Rojas-Martinex, Julio
    Rosen, Howard
    La Joie, Renaud
    Lesman-Segev, Orit
    Iaccarino, Leonardo
    Kollmorgen, Gwendlyn
    Ljubenkov, Peter
    Eichenlaub, Udo
    Gorno-Tempini, Maria Luisa
    Miller, Bruce
    Hansson, Oskar
    Rabinovici, Gil Dan
    NEUROLOGY, 2022, 98 (11) : E1137 - E1150